IMIC(SZ:000516) Sou Hu Cai Jing·2025-11-12 13:48Core Viewpoint - International Medical (000516) has shown a slight increase in stock price, but the financial performance indicates significant challenges, with declining revenues and profits [1][3]. Financial Performance - As of November 12, 2025, the stock closed at 5.01 CNY, up 1.83% with a trading volume of 464,800 shares and a total transaction value of 231 million CNY [1]. - For the first three quarters of 2025, the company reported a main business revenue of 2.995 billion CNY, a year-on-year decrease of 16.94%, and a net profit attributable to shareholders of -294 million CNY, down 38.45% [3]. - The third quarter alone saw a revenue of 961 million CNY, a decline of 18.95%, and a net profit of -129 million CNY, a staggering drop of 234.24% [3]. Market Position and Ratios - The total market capitalization of International Medical is 11.217 billion CNY, ranking 12th in the medical services industry, which has an average market cap of 19.516 billion CNY [3]. - Key financial ratios include a price-to-earnings ratio of -28.65 and a price-to-book ratio of 3.36, with a gross margin of 6.59%, significantly lower than the industry average of 35.56% [3]. Investment Ratings - In the last 90 days, two institutions have provided ratings for the stock, with one buy rating and one hold rating [4].